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An essential step• in the immune response of Harfley strain guinea pigs to poly-L- 
lysine  (PLL) and  to hapten conjugates of this homopolymer (H-PLL) is under the 
control of a dominant autosomal gene which will be designated as the PLL gene. This 
gene is also required for the recognition of the antigenicity of copolymers of l.-lysine 
and L-glutamic acid (GL) (1-3). The exact process controlled by the PLL gene in the 
immune response to these synthetic antigens has not been determined but is clearly 
a  reaction specific for a  configuration determined by a  sufficient  number of repeated 
adjacent lysyl residues which characterize these synthetic polymers and their  conju- 
gates.  Hapten  conjugates of oligo-L-lysines  must contain a  minimum  of  7-8  lysyl 
residues in order to be recognized as antigens by genetic responder guinea pigs (4,5). 
Guinea pigs lacking the PLL gene and incapable of an immune response against 
2,4-dinitrophenyl-poly-L-lysine (DNP-PLL) can nevertheless recognize this molecule 
as a hapten. Thus, following immunization with electrostatic aggregates of DNP-PLL 
and foreign  albumins,  such  nonresponder animals  produce  large  amounts of anti- 
DNP-PLL antibodies  with  apparently  identical  specificity,  as  judged  by  available 
techniques, for  the  PLL  molecule as that found in antibodies  produced by genetic 
responders immunized with DNP-PLL alone (6). 
There is,  however, a  very significant difference  in the immune response to DNP- 
PLL of these  two types of animals.  Genetic responders immunized with DNP-PLL 
in complete Freund's adjuvant show delayed hypersensitivity reactions to DNP-PLL 
and their lymph node cells in vitro respond to DNP-PLL with an increase in DNA 
synthesis.  1 Such reactions are characteristic of the response of actively sensitized  cells 
to antigen in vivo and  in vitro.  In contrast,  guinea pigs lacking the PLL gene ira- 
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munized  with  complexes  of  DNP-PLL  and  bovine  serum  albumin  or  ovalbumin 
(OVA) do not show either of these reactions to DNP-PLL. These experiments demon- 
strate  that an identical,  although not precisely defined step, controlled by the PLL 
gene is required for recognition of the immunogenicity of H-PLL conjugates and for 
the specific  response of actively sensitized cells  to this antigen in vivo and in vitro. 
Similar conclusions were reached by Schlossman et al.  (4,5)  concerning the speci- 
ficity requirements  for the induction of the primary immune  response and  for the 
elicitation of delayed hypersensitivity reactions with DNP-oligo-L-lysines as antigens. 
Conjugates with the same minimum number of 7-8 lysyl residues are essential both 
for immunization of responder guinea pigs and for the elicitation of delayed hyper- 
sensitivity reactions in these animals. 
In order to more precisely define the nature of the process controlled by the 
PLL gene,  a  study was made of the ability of lymph node cells from genetic 
responder  guinea pigs immunized  with  DNP-PLL  or DNP-GL  to  passively 
transfer delayed hypersensitivity to guinea pigs with or without the PLL gene. 
In addition,  the lymph node cells from nonresponder  guinea pigs immunized 
with  DNP-PLL. OVA  complexes  were  transferred  to  genetic  responder  and 
nonresponder  animals  and  the  recipients  were tested  for the presence  of  de- 
layed hypersensitivity to DNP-PLL. In these experiments delayed hypersensi- 
tivity to DNP-PLL or to DNP-GL could be transferred successfully only with 
sensitized cells from genetic responder guinea pigs  and, in most  cases, only to 
those recipient guinea pigs which possessed the PLL  gene. 
Materials and Methods 
Polypeptides  and  Proleins.--Poly-rAygme  (PLL)  hydrobromide  with average  molecular 
weight of 90,000 and a copolymer of 60% gintamic acid and 400/o lysine (GL) with an average 
molecular weight of 115,000 were obtained from Pilot Chemical Co., Watertown, Mass. Oval- 
bumin (OVA) was obtained from Pentex,  Inc., Kankakee, Ill. 
Other Reagonts.--Complete  Freund's adjuvant was obtained from Difco Laboratories, Inc., 
Detroit,  Mich.  1-fluoro-2,4-dinitrobenzene (DNFB) was purchased  from Eastman Organic 
Chemicals, Rochester, N.Y. Tissue culture medium 199 (TC 199) was obtained from Micro- 
biological Associates, Bethesda, Md. 
Preparation  of Conjuga~s.--2,4-dinitrophenyl  (DNP)  conjugates  were prepared  by the 
reaction of PLL or GL with DNFB in p-dioxane under alkaline conditions as previously de- 
scribed  (1). Polypeptide  and protein  concentrations were determined  by miero-Kjeldatfl ni- 
trogen  analyses.  The degree of DNP substitution  was calculated  from  the absorbancy  at 
360 m/z on the basis of the molar extinction coefficient  of free ~-DNPoL-lysine  (~ =  17,400) (7). 
The following conjugates were prepared:  DNP20-PLL43t , DNP35-PLL4~t and  DNP24-GL. 
The subscripts refer respectively to the average number of groups of hapten and the average 
number of amino acid residues in the molecule. 
Preparation of DNP-PLL. OVA Complexes.---Ovalbumin at a concentration of 5 mg/ml in 
water was added to an equal volume of DNP-PLL at a concentration of 5 mg/ml in water; 
0.1 st NaOH was added dropwise until a precipitate  formed. 
Immunization  of Donor Animals.--Random-bred  Hartley strain guinea pigs weighing 300- 
400 g were purchased from Carom Research Inc., Wayne, N. J. These animals were immu- ,P>. 
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nized in the four footpads with either 100 #g of DNP-PLL or DNP-GL in 0.4 ml of an emul- 
sion containing Freund's adjuvant or with 200 ~g of DNP-PLL. OVA complex in 0.4 ml of 
an  emulsion  containing  Freund's  adjuvant.  The  animals  immunized  with  DNP-PLL  or 
DNP-GL were skin tested at 8 days with 10/~g of the immunizing antigen. The animals immu- 
nized with DNP-PLL- OVA complex were skin tested at 8  days with 10 Dg of DNP-PLL and 
with 20/~g DNP-PLL. OVA complex, Delayed hypersensitivity reactions were evaluated at 
24 hr. Genetic responder animals were identified by their delayed hypersensitivity reaction 
to DNP-PLL  (6). 
Rexipi~ Anima/s.--Random-bred normal Hartley guinea pigs weighing 300-400 g from 
Carom Research Inc. were used as recipient animals. About 30% of these animals carry the 
PLL gene. Also two recipient Hartley strain guinea pigs which were the offspring of genetic 
responder guinea pigs were kindly provided by Dr. B. B. Levine. 
Method of Tra~fer.--A diagram of the experimental design is shown in Fig. I. Genetic re- 
sponder or genetic nonresponder donor guinea pigs were selected on the basis of their delayed 
hypersensitivity reactions to DNP-PLL or to DNP-GL. The animals were killed and all ac- 
cessible peripheral lymph nodes were removed, dissected free of fat, teased apart in TC 199, 
and filtered through gauze. The cell suspensions prepared in this manner were then centrifuged 
at 700 rpm for 7 rain at room temperature. The supernatant media was discarded and the cell 
button was resuspended in 2 ml of fresh TC 199. The cells of three donors were given intra- 
venously to one recipient animal. Approximately l0  g cells were transferred to each recipient 
guinea pig. Each recipient animal was individually and distinctly marked. The recipient ani- 
mals were skin tested with 10/~g of DNP-PLL or 50 #g of DNP-GL  1 hr after transfer. In 
those animals receiving cells from donors imm,nlzed with DNP-PLL. OVA, skin tests with 
10 or 50 #g of OVA were also performed. The skin reactions of the recipient animals were read 
24 Jar later. Since 10/~g of DNP-PLL produced a  small inflammatory skin reaction (4-5 mm 
in diameter) in normal guinea pigs, control nonimmunized guinea pigs were injected with the 
test antigen in each experiment. The reactions in the recipient animals were compared with 
the reactions of untreated animals and scored as either positive or negative on the basis of the 
severity and size of induration and erythema. 
In this manner, it was established whether a successful transfer of delayed hypersensitivity 
had been effected in the recipient animals without knowledge of whether the animals carried 
the PLL gene. The geneticstatus of the recipient animals was subsequently determined by a 
test of their ability to be actively immunized by DNP-PLL and by GL. Thus, 4 days after 
the passive transfer of cells sensitive to DNP-PLL the recipients were immunized with 100 #g 
of DNP-PLL and 100 #g of GL in complete adjuvant. After the passive transfer of cells sens- 
tive to DNP-GL the recipient animals were immunized only with DNP-PLL. The capacity 
to form an active immune response to these antigens was tested by the presence of delayed 
hypersensitivity and of serum antibodies. Anti-DNP antibodies were tested for by gel diffusion 
analysis with DNP  guinea pig albumin or by  equilibrium dialysis withSH-DNP-e-amino  - 
eaproic acid as previously described (6). Anti-GL antibodies were assayed by passive cutan- 
eous anaphylaxls (8). It should be noted that no error could be expected to occur in deter- 
mining the "responder status" as a  result of  the activity of the transferred sensitive cells 
because these cells would be expected to have been rejected by the time the actual immune 
response is established (12 days). In addition, delayed hypersensitivity reactions to  GL and 
to  DNP-PLL  are not cross-reactive; the same is true of delayed hypersensitivity reactions 
to DNP-GL and to DNP-PLL  (1). 
Recipient animals classified as genetic responders showed both delayed hypersensitivity 
reactions to theimmunlzing  antigens and specific antibodies in their sera. Genetic nonresponder 
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RESULTS 
Sensitized  cells from genetic  responder  guinea pigs immunized  with DNP- 
PLL or with DNP-PLL. OVA  (group I)  transferred  delayed  hypersensitivity 
to DNP-PLL  to  14 of 37  recipient  guinea  pigs  (Table  ! ).  Of the 14 recipient 
animals with successful transfers,  12 were shown to possess the PLL gene and 
TABLE I 
Success or Failure of Transfer of Ddayed Hypersensiti~ty to DNP-PLL and to DNP-GL into 
Recipient Guinea Pigs with and without the PLL Gene 
Group 
I 
II 
III 
Genetic status of 
donor animals* 
PLL gene positive 
PLL gene positive 
PLL gene negative 
Immunological 
specificity 
transferred 
DNP-PLL 
DNP-GL 
DNP-PLL 
blo. of recipient 
animals 
37~ 
21 
2111 
Positive 
transfer to 
genetic 
resl?onder 
ammals 
12/12§ 
6/7 
0/6 
Positive 
transfer to 
genetic 
nonresponder 
anlraals 
2/25 
1/14 
o/Is 
* The lymph node ceils of three immunized  donor animals were used for each recipient. 
Approximately 10  ° ceils were injected per animal. 
19 of these 37 animals received ceils from guinea pigs immunized with DNP-PLL. OVA 
complexes.  Seven of these 19 animals were responders and in all seven, delayed sensitivity to 
OVA was transferred together with delayed hypersensitivity to DNP-PLL. The remaining 
twelve animals were nonresponder guinea pigs. Eight of these showed a transfer of delayed sen- 
sitivity to OVA in the absence of transfer of delayed sensitivity to DNP-PLL. 
§ The numerator refers to the number of animals in which a successful transfer was ac- 
complished  and the denominator refers to the number of animals of that genetic type indi- 
cated in the column  above. 
It 15 of these 21 animals received cells from guinea pigs immunized with DNPoPLL.OVA. 
All of these 15 animals had a positive transfer of delayed hypersensitivity to OVA in the ab- 
sence of a transfer of delayed reaction to DNP-PLL; five of these 15 recipient  guinea pigs 
were  responder  animals. 
two were nonresponder guinea pigs. All of the 23 animals which failed to receive 
the transfer were shown to be genetic nonresponders. Thus all recipient animals 
with the PLL gene and only two of the 25 genetic nonresponder  animals mani- 
fested positive transfer of delayed hypersensitivity  to DNP-PLL. 
Similar results were obtained in transfer experiments of delayed hypersensi- 
tivity  to  DNP-GL  from responder  guinea  pigs  (group  II).  Seven  out  of 21 
recipient  animals  showed  successful  transfers;  of  these  positive  animals,  six 
were shown to have the PLL gene and one was a  nonresponder  guinea pig. Of 
the 14 animals which failed to receive the transfer,  13 were later demonstrated 
to be genetic nonresponders.  Thus six of seven genetic responders  and one of 
14  genetic  nonresponder  guinea  pigs  showed  a  successful  transfer  of delayed 
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These experiments  demonstrate that transfer of delayed hypersensitivity to 
antigens whose immunogenicity is controlled by the PLL gene is only achieved 
regularly in recipient  guinea pigs who also possess the gene. 
A  third  group  of  donor  animals  (group  III),  lacking  the  PLL  gene, 
were immunized with DNP-PLL or with DNP-PLL-OVA complexes. These 
animals did not show delayed hypersensitivity reactions to DNP-PLL. When 
their lymph node cells were transferred to 21 guinea pigs, none of the recipients 
developed  reactions to DNP-PLL, although 6 of these recipient  guinea pigs 
were later shown to possess the PLL gene. Animals lacking the PLL gene can be 
induced to form anti-DNP-PLL antibodies by immunization with DNP-PLL. 
OVA (6). Such animals do not exhibit delayed hypersensitivity to DNP-PLL 
and, as shown in the  present  experiment,  cannot passively transfer delayed 
reactions to DNP-PLL to animals possessing the PLL gene. 
To investigate whether delayed reactions  to other antigens, the immuno- 
genicity of which is not controlled by the PLL gene, can be transferred between 
genetic responder and nonresponder  animals, a study was made of the transfer 
of delayed hypersensitivity to ovalbumin in guinea pigs immunized with DNP- 
PLL.  OVA complexes. 19 of the 37 animals in group I received cells from donor 
animals immunized with DNP-PLL. OVA. Seven of these recipients possessed 
the PLL gene and all showed a transfer of delayed hypersensitivity to oval- 
bumin. The remaining twelve animals lacked the PLL gene; transfer of delayed 
hypersensitivity  to ovalbumin  was successful in nine of these guinea pigs. 15 ani- 
mals in group III received cells from nonresponder  guinea pigs immunized with 
DNP-PLL-OVA. All showed  a  successful transfer of ovalbumin sensitivity. 
Five of the animals were genetic responders and 10 lacked the PLL gene. These 
experiments  indicate that the transfer of delayed hypersensitivity to an unre- 
lated antigen, ovalbumin, is easily achieved from guinea pigs lacking the PLL 
gene to guinea pigs with the PLL gene. This was also achieved in nine out of twelve 
instances  of transfer from genetic responder  to nonresponder  guinea pigs.  It 
should be noted that in eight of the nine cases, ovalbumin sensitivity was trans- 
ferred in the absence of transfer of sensitivity  to DNP-PLL. These findings indi- 
cate that the failure to transfer DNP-PLL sensitivity  to these eight  nonresponder 
recipients  is not caused by an early destruction of the transferred donor cells. 
DISCUSSION 
An analysis of the passive transfer of delayed hypersensitivity to those syn- 
thetic antigens the hnmunogenicity of which is controlled  by  the  PLL gene 
reveals that actively sensitized lymph node cells from responder animals fail, in 
most cases, to transfer delayed hypersensitivity reactions  to guinea pigs which 
lack the PLL gene. It should be noted that these cell populations although in- 
capable  of mediating this transfer to genetic  nonresponder  animals  are  fully IRA  GREEN,  WILLIAM  E.  PAUL,  A_N'D BARUJ  BENACERRAF  965 
capable of being stimulated by DNP-PLL in vitro as shown by an increase  in 
DNA synthesis after exposure of these cells to this antigen. 1 
Delayed hypersensitivity reactions have been considered to be elicited by 
the reaction of sensitized cells with antigen in vivo. Several  conclusions  can be 
drawn from these experiments.  (a)  The  transfer  of delayed hypersensitivity 
reactions with actively sensitized ceils requires the active participation of host 
mechanisms.  (b)  The  hypothesis  (9)  that  delayed hypersensitivity reactions 
are caused by the local reaction of very high-affinity  circulating antibody with 
antigen  is not compatible with these transfer experiments which indicate an 
essential and active process by the recipient animal.  (c) The same immunological 
properties of antigens are necessary for the induction of the immune response 
and for the elicitation of delayed hypersensitivity reactions. It is well known 
that unreactive haptens or incomplete antigens are incapable of eliciting delayed 
hypersensitivity reactions (10, 11). This is further illustrated by the failure of 
DNP-PLL to elicit delayed reactions in nonresponder guinea pigs immunized 
with DNP-PLL. OVA (6), and by the failure of ot-DNP-PLL8 with only six  ly- 
syl  residues  to  elicit delayed reactions in  responder  guinea  pigs  immunized 
with a-DNP-PLIa (4, 5). The present studies extend these earlier observations 
and indicate that with these antigens, the ability to form an immune response, 
to show delayed hypersensitivity reactions, and to be capable of expressing a 
passive transfer of delayed hypersensitivity involves the activity of the same 
genetically controlled mechanism. 
The nature of the process governed by the PLL gene in inducing the immune 
response and in allowing  the expression  of  delayed hypersensitivity to these 
synthetic antigens  is unclear.  The demonstration  that  the transfer  of lymph 
node cells sensitive to DNP-PLL to animals lacking the PLL gene  generally 
does not transfer delayed hypersensitivity to DNP-PLL suggests  that  some 
essential  genetically controlled processing step on the antigen,  specific for L- 
]ysine sequences,  must take place before sensitized  cells capable of binding the 
antigenic determinants  can be stimulated by such antigen.  An identical  pro- 
cessing step can be postulated to be also required for initiation of the immune 
response to antigens,  the immunogenicity of which is controlled by the PLL 
gene.  Such a processing step may take place in macrophages as suggested by 
the experiments of Fishman and Adler (12), Friedman et al. (13), and Askonas 
and Rhodes (14). The small number of macrophages of proper genetic type in 
passively administered donor lymph node cell suspensions  may not be sufficient 
to perform this duty and thus no delayed reaction ensues. 
The observation that nonresponder guinea pigs immunized with DNP-PLL. 
OVA complexes  do not show delayed reactions to DNP-PLL in spite of the 
synthesis of anti-DNP-PLL  antibodies, and are not able to transfer  delayed 
reactions  to DNP-PLL to guinea pigs possessing  the PLL gene,  requires  an 966  GENETIC  CONTROL  O~ PASSIVE  TRANSFER 
explanation  consistent  with  the  above  interpretation.  The  data  presented 
indicate that no cells are produced which can be stimulated specifically by DNP- 
PLL in nonresponder guinea pigs immunized with DNP-PLL. OVA aggregates. 
This fact is also confirmed by the inability of DNP-PLL added in tissue culture 
to stimulate DNA synthesis by lymph node cells from these animals} How can 
these phenomena be explained if the PLL gene controls a specific processing 
step on the antigen in the initiation of the immune response?  One would need 
to postulate that the processing of the ovalbumin conveyor molecule in genetic 
nonresponder animals immunized with DNP-PLL-OVA, which is required to 
produce anti-DNP-PLL antibodies in such animals, cannot result in the develop- 
ment of cells capable of responding to DNP-PLL alone.  In this sense no cell 
which can react specifically to DNP-PLL can be formed by nonresponder guinea 
pigs because the stimulation of such cells requires the proper processing of this 
antigen which nonresponder guinea pigs cannot perform. 
Genetic nonresponder  animals  are capable of displaying adoptive delayed 
sensitivity to ovalbumin but not to DNP-PLL. It can be postulated therefore 
that in more complex antigens such as ovalburoln a variety of sites exist for 
the operation of genetically controlled processing  steps of similar  nature but 
different specificities.  Thus,  in the case of more complex antigens one rarely 
appreciates the presence or absence of a single processing  gene. 
Another possibility, not mutually exclusive with the first,  is that the inter- 
action between the donor cells and processed antigen is not the sole requirement 
in the expression  of the delayed reaction but requires,  in addition,  the active 
participation  at later steps of host mononuclear cells of proper genetic type. 
The importance of host mononuclear cells for the proper expression  of passive 
transfer of delayed sensitivity has been recently emphasized by other authors 
(15, 16). 
S~&RY 
A study of the passive transfer of delayed hypersensitivity to DNP-poly-L- 
lysine and to DNP-GL was performed in Hartley guinea pigs. Delayed hyper- 
sensitivity to DNP-PLL and DNP-GL could be transferred successfully only 
by means of sensitized  cells from genetic responder  guinea pigs and  in  most 
cases, only into those guinea pigs genetically capable of responding  to PLL. 
The inability to transfer delayed hypersensitivity to DNP-PLL or DNP-GL 
to genetic nonresponder guinea pigs is not the result of the early destruction of 
the transferred cells by an incompatible host, since it was shown that delayed 
hypersensitivity to ovalbumin could be successfully  transferred  from guinea 
pigs with the PLL gene into genetic nonresponder animals. 
The requirement of active participation of specific and genetically controlled 
host mechanisms in the  successful  passive transfer  of delayed sensitivity to 
DNP-PLL and DNP-GL has been demonstrated. IRA  GREEN'~  WILLIAM  E.  PAUL~  AND  BARUJ  BENACERRAF  967 
BIBLIOGRAPHY 
1.  Kantor, F. S., A. Ojeda,  and B. Benacerraf. 1963. Studies  on artificial  antigens. 
I. Antigenicity of DNP-polylysine and DNP-copolymers of lysine and glutamic 
acid in guinea pigs. I. gxpa. Meal. 117:55. 
2.  Levine, B. B., A. Ojeda,  and B. Benacerraf. 1963.  Studies  on artificial  antigens. 
III. The genetic control of the  immune response  to hapten-poly-L-lysine con- 
jugates in guinea pigs. J. Exptl. Meal. 118:953. 
3.  Levine, B. B., and B. Benacerraf. 1964. Genetic control in guinea pigs of the im- 
mune response to conjugates of haptens and poly-z-lysine.  Science.  147:517. 
4.  Schlossman,  S.  F.,  A Yaron,  S.  Ben-Efraim, and H. A. Sober.  1965. Immunoge- 
nicity of a series of a-N-DNP-L-lysines. Biochemistry. 4:1638. 
5.  Schlossman,  S.  F.,  S.  Ben-Efraim, A. Yaron, and H. A.  Sober.  1966. Immuno- 
chemical  studies on the antigenic determinants required  to elicit  delayed and 
immediate hypersensitivity reactions.  J. Exptl. Meal. 123:1083. 
6.  Green, I., W. E. Paul, and B. Benacerraf. 1966. The behavior of hapten-poly-L- 
lysine conjugates as complete antigens in genetic responders and as haptens in 
nonresponder guinea pigs. J. Exptl. Med. 123:859. 
7.  Carsten, M. E., and H. N. Eisen.  1953. The interaction of dinitrobenzene  deriva- 
tives with bovine serum albumin. J. Am. Chem.  Soc.  75:4451. 
8.  Ovary, Z. 1964. Passive cutaneous anaphylaxis. In Immunological Methods. J. F. 
Ackroyd, editor. F. A. Davis Company, Philadelphia.  259. 
9.  Karush, F., and H. N. Eisen.  1962. A theory of delayed hypersensitivity. Science. 
136:1032. 
10.  Eisen, H. N. 1959. Hyersensitivity to simple chemicals.  In Cellular and Humoral 
Aspects of the Hypersensitive States. H. S. Lawrence,  editor. P. B. Hoeber, Inc., 
New York. 89. 
11.  De Weck, A. L., E. Vogler, J. R. Frey, and H. Geleick.  1966. The induction  of 
contact hypersensitivity dinitrochlorobenzene  (DNCB)  in guinea pigs by di- 
nitrophenyl-amino acids. Intern. Arch. Allergy A ppl. Immunol.  29:174. 
12.  Fishman,  M., and  F.  L.  Adler.  1963. Antibody formation initiated in vitro. J. 
Exptl. Med. 117:595. 
13.  Friedman, H. P., A. B. Stavitsky, and J. M. Solomon. 1965. Induction in vitro of 
antibodies to phage T2; antigens in the RNA extract employed. Science.  149:1106. 
14.  Askonas,  B. A., and J. M. Rhodes.  1965. Immunogenicity of antigen containing 
ribonucleic  acid preparations from macrophages. Nature.  205:470. 
15.  Elkins, W. L. 1966. The interaction of donor and host lymphoid cells in the patho- 
genesis of renal cortical destruction induced by a local graft versus host reaction. 
J. Exptl. Med. 123:103. 
16.  Coe, J. E., J. D. Feldman, and S. Lee. 1966. Immunologic competence of thoracic 
duct cells. I. Delayed hypersensitivity. J. Exptl. Med. 123:267. 